Cargando…

Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings

BACKGROUND: Outbreaks of new HIV transmission among people who inject drugs (PWID) are a major public health concern. Oral daily PrEP, has been identified as a critical addition to the biomedical toolkit for this population. However, limited research on the acceptability of long-acting injectable Pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	King, Adrian R., Shah, Saanchi, Randall, Laura A., Frew, Paula M., Spaulding, Anne, Holloway, Ian W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473463/ https://www.ncbi.nlm.nih.gov/pubmed/36104676 http://dx.doi.org/10.1186/s12879-022-07572-3

Ejemplares similares

Violence Victimization, Homelessness, and Severe Mental Illness Among People Who Use Opioids in Three U.S. Cities
por: Hong, Chenglin, et al.
Publicado: (2023)

Health Behavior Survey Among People Who Use Opioids: Protocol for Implementing Technology-Based Rapid Response Surveillance in Community Settings
por: Frew, Paula M, et al.
Publicado: (2021)

Identifying Missed Opportunities for Routine Vaccination among People Who Use Drugs
por: Frew, Paula M., et al.
Publicado: (2021)

COVID‐19 vulnerability among people who use drugs: recommendations for global public health programmes and policies
por: Holloway, Ian W, et al.
Publicado: (2020)

Vaccine confidence among people who use drugs: A cross-sectional survey
por: Frew, Paula M., et al.
Publicado: (2022)

Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
por: Pleuhs, Benedikt, et al.
Publicado: (2022)

Oral Pre-Exposure Prophylaxis (PrEP) Awareness and Acceptability Among Persons who Inject Drugs (PWID) in Kenya: A Qualitative Investigation
por: Cosmas, Mugambi, et al.
Publicado: (2023)

The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2023)

Acceptability of supervised injection facilities among persons who inject drugs in upstate New York
por: Duncan, Eliana, et al.
Publicado: (2022)

The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review
por: Guy, Danielle, et al.
Publicado: (2022)

Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs
por: Dubov, Alex, et al.
Publicado: (2023)

Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
por: Adeagbo, Oluwafemi, et al.
Publicado: (2021)

HIV and Addiction Services for People Who Inject Drugs: Healthcare Provider Perceptions on Integrated Care in the U.S. South
por: Bradford, Davis, et al.
Publicado: (2023)

HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research
por: Escudero, Daniel J, et al.
Publicado: (2014)

Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men
por: Dean, Lorraine T., et al.
Publicado: (2023)

Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
por: Cheng, Chih-Yuan, et al.
Publicado: (2019)

Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs
por: Biello, K. B., et al.
Publicado: (2018)

HIV Infection Care and Viral Suppression Among People Who Inject Drugs, 28 U.S. Jurisdictions, 2012-2013
por: Karch, Debra L., et al.
Publicado: (2016)

2089. Relative patient preferences for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among US men who have sex with men, 2021-2022
por: Sanchez, Travis, et al.
Publicado: (2022)

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial
por: Baxi, Sanjiv M., et al.
Publicado: (2018)

Cost effectiveness of ‘on demand’ HIV pre-exposure prophylaxis for non-injection drug-using men who have sex with men in Canada
por: Ouellet, Estelle, et al.
Publicado: (2015)

50. Pilot Study on Offering HIV Pre-Exposure Prophylaxis (PrEP) to People Who Inject Drugs (PWID) in the Inpatient Setting
por: Marryshow, Terry A, et al.
Publicado: (2021)

Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery
por: Shaw, Graham, et al.
Publicado: (2023)

Deciphering the Effects of Injectable Pre-exposure Prophylaxis for Combination Human Immunodeficiency Virus Prevention
por: Glaubius, Robert L., et al.
Publicado: (2016)

Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
por: Moyo, Enos, et al.
Publicado: (2022)

Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City
por: Mitra, Sanjana, et al.
Publicado: (2017)

Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic
por: Jayakumaran, Jenani Sarah, et al.
Publicado: (2016)

Acceptability of Pre-Exposure Prophylaxis and Non-Occupational Post-Exposure Prophylaxis among Men Who Have Sex with Men in Guilin, China
por: Zhou, Lingmi, et al.
Publicado: (2022)

Preferences for pre-exposure prophylaxis among U.S. military men who have sex with men: results of an adaptive choice based conjoint analysis study
por: Gutierrez, José I., et al.
Publicado: (2021)

Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men
por: Zhou, Feng, et al.
Publicado: (2012)

Applying National Estimates of Adults With Indications for Pre-Exposure Prophylaxis to Populations of Men Who Have Sex With Men and People Who Inject Drugs in Colorado: Modeling Study
por: Donnelly, Jennifer A, et al.
Publicado: (2019)

Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis
por: Levy, Matthew E., et al.
Publicado: (2017)

Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA
por: Barry, Michael P., et al.
Publicado: (2022)

Housing unit and urbanization estimates for the continental U.S. in consistent tract boundaries, 1940–2019
por: Markley, Scott N., et al.
Publicado: (2022)

Acceptability and feasibility of long-acting injectable antiretroviral therapy for HIV-infected persons who inject drugs in Vietnam: A qualitative study
por: Rutstein, Sarah E., et al.
Publicado: (2022)

CDC Grand Rounds: Preventing Unsafe Injection Practices in the U.S. Health-Care System
por: Birkhead, Guthrie, et al.
Publicado: (2013)

Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand
por: Yang, Daniel, et al.
Publicado: (2013)

Correction: Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men
por: Zhou, Feng, et al.
Publicado: (2012)

Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention
por: Walters, Suzan M., et al.
Publicado: (2017)

Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria
por: Nishimoto, Lirica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gi9thv7uakvdlfs45vfgjm9s7c